Applying the intervention Complexity Assessment Tool to brief interventions targeting long-term benzodiazepine receptor agonist use in primary care: Lessons learned
- PMID: 35842593
- PMCID: PMC9288038
- DOI: 10.1186/s12875-022-01775-y
Applying the intervention Complexity Assessment Tool to brief interventions targeting long-term benzodiazepine receptor agonist use in primary care: Lessons learned
Abstract
Background: Benzodiazepine receptor agonists (BZRAs) are often prescribed for long-term use. However, guidelines recommend limiting prescriptions to short-term use (< 4 weeks) to reduce the risk of adverse effects and dependence. A recent systematic review reported that brief interventions targeting long-term BZRA use in primary care (e.g., short consultations, written letters to patients) were effective in helping patients to discontinue BZRA medication. However, the complexity of these interventions has not been examined in detail. This study aimed to apply the intervention Complexity Assessment Tool for Systematic Reviews (iCAT_SR) to brief interventions targeting long-term BZRA use. METHODS: Two reviewers independently assessed the interventions using the six core iCAT_SR dimensions: organisational level/ category targeted, behaviour targeted, number of intervention components, degree of tailoring, skill level required by those delivering and receiving the intervention. The four optional iCAT_SR dimensions were applied where possible. A scoring system was using to calculate a complexity score for each intervention. Pearson's correlations were used to assess the relationship between intervention complexity and effect size, as well as the relationship between intervention complexity and number of component behaviour change techniques (BCTs). Inter-rater reliability was calculated using Cohen's Kappa coefficient.
Results: Four of the six core iCAT_SR dimensions were applied to the interventions with high inter-rater reliability (Cohen's Kappa = 0.916). Application of the four optional dimensions was prevented by a lack of detail in study reports. Intervention complexity scores ranged from 8 to 11 (median: 11). There was no relationship detected between intervention complexity and either intervention effect size or number of component BCTs.
Conclusions: This study adds to the literature on worked examples of the practical application of the iCAT_SR. The findings highlight how more detailed reporting of interventions is needed in order to optimise the application of iCAT_SR and its potential to differentiate between interventions across the full range of complexity dimensions. Further work is needed to establish the validity of applying a scoring system to iCAT_SR assessments.
Keywords: Behaviour change techniques; Benzodiazepines; Brief interventions; Intervention complexity; Systematic review; Z-drugs; iCAT_SR.
© 2022. The Author(s).
Conflict of interest statement
The authors declare that they have no competing interests.
Similar articles
-
Application of the intervention Complexity Assessment Tool for Systematic Reviews within a Cochrane review: an illustrative case study.HRB Open Res. 2020 Jun 1;3:31. doi: 10.12688/hrbopenres.13044.1. eCollection 2020. HRB Open Res. 2020. PMID: 32596632 Free PMC article.
-
Assessing the complexity of interventions within systematic reviews: development, content and use of a new tool (iCAT_SR).BMC Med Res Methodol. 2017 Apr 26;17(1):76. doi: 10.1186/s12874-017-0349-x. BMC Med Res Methodol. 2017. PMID: 28446138 Free PMC article.
-
Brief interventions targeting long-term benzodiazepine and Z-drug use in primary care: a systematic review and meta-analysis.Addiction. 2020 Sep;115(9):1618-1639. doi: 10.1111/add.14981. Epub 2020 Feb 11. Addiction. 2020. PMID: 31985127 Free PMC article.
-
Supporting safe and gradual reduction of long-term benzodiazepine receptor agonist use: Development of the SAFEGUARDING-BZRAs toolkit using a codesign approach.Health Expect. 2022 Aug;25(4):1904-1918. doi: 10.1111/hex.13547. Epub 2022 Jun 7. Health Expect. 2022. PMID: 35672924 Free PMC article.
-
Psychological interventions for improving adherence to inhaled therapies in people with cystic fibrosis.Cochrane Database Syst Rev. 2023 Mar 29;3(3):CD013766. doi: 10.1002/14651858.CD013766.pub2. Cochrane Database Syst Rev. 2023. PMID: 36989170 Free PMC article. Review.
References
-
- Benzodiazpine Committee . Benzodiazepines: Good Practice Guidelines for Clinicians. Dublin: Department of Health and Children; 2002.
-
- National Institute for Health and Clinical Excellence . Guidance on the use of zaleplon, zolpidem and zopiclone for the short-term management of insomnia. 2004.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Research Materials